Nick Staples appointed as interim CEO and Jon Moore as NED Nick Staples appointed as interim CEO and Jon Moore as NEDindigo tree2022-03-28T19:50:29+01:00November 16th, 2020|Read More
Avvinity’s Head of Chemistry presents at the Immuno-Oncology Summit Avvinity’s Head of Chemistry presents at the Immuno-Oncology Summitindigo tree2020-10-20T23:11:26+01:00October 16th, 2020|Read More
LifeArc invests in Avvinity Therapeutics LifeArc invests in Avvinity Therapeuticsindigo tree2020-11-09T17:33:43+00:00October 14th, 2020|Read More
Avvinity Chief Scientific Officer presents at ELRIG Webinar Avvinity Chief Scientific Officer presents at ELRIG Webinarindigo tree2020-10-20T23:32:31+01:00October 12th, 2020|Read More
